Hyperactive WNT signaling is a potent cancer driver but clinical translation of WNT inhibitors has been hampered by on-target toxicities. WNT signaling can be constrained through inhibition of the PARP-family enzymes tankyrase 1 (TNKS1) and TNKS2; however, existing TNKS inhibitors suppress WNT signaling in both tumor a...
Jill Zimmerman, Brandon F. Malone, Kevan Chu et al.· Nature Chemical Biology· 1 citation
Intratumoral heterogeneity is a defining feature of pancreatic ductal adenocarcinoma (PDAC), yet how distinct malignant cell states contribute to tumor behavior and stromal diversity in situ remains poorly understood. PDAC contains recurrent classical and basal states, with basal-dominant tumors associated with aggre...
Kate Ryan, A. Singhal, Samuel A. Rose et al.· Cancer Research· 0 citations
It is shown that P-selectin is expressed by a subset of senescent-like cells in fibrotic tissues and tumors, which establishes SMNPs as a generalizable strategy to target pathogenic senescent cell subsets across fibrosis and cancer.
Clemens Hinterleitner, Valentin J. A. Barthet, Hailey V. Goldberg et al.· Science· 1 citation
These findings uncover CAF–bone-marrow cross-talk as a therapeutic target linking stromal inflammation, immune remodeling, and metastatic progression as a therapeutic target linking stromal inflammation, immune remodeling, and metastatic progression.
Yasuto Takeuchi, Hua-Zi Zhang, T. Murayama et al.· bioRxiv· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.